Splash
Splash

News & SEC Filings

News

View all news
July 27 2021Regulatory
Verona Pharma Announces August 2021 Virtual Investor Conference Participation

LONDON and RALEIGH, N.C., July 27, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present at the

July 22 2021Financial News, Regulatory
Verona Pharma to Report Second Quarter 2021 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the three and six months ended June 30, 2021 on

June 10 2021Company News, Financial News, Regulatory
Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China

$40 million upfront including $25 million cash and $15 million in equity in Nuance Biotech (parent company). Up to $179 million in potential clinical, regulatory, and commercial milestone payments plus tiered double-digit royalties. Nuance Pharma is responsible for all costs related to development and commercialization of ensifentrine in China.

May 25 2021Regulatory
Verona Pharma to Present at Jefferies Virtual Healthcare Conference

LONDON and RALEIGH, N.C., May 25, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company overview at the

May 4 2021Company News, Regulatory
Verona Pharma to Present Expanded Analysis of Phase 2b COPD Data with Ensifentrine at the American Thoracic Society 2021 International Conference

Posters highlight ensifentrine’s safety profile and its potential to improve lung function and quality of life irrespective of COPD severity LONDON and RALEIGH, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company

SEC Filings

Group

Year

DateDescriptionFormFiling GroupView
Jul 20 2021Amendment to a previously filed 8-K8-K/ACurrent Reports
Jun 11 2021Report of unscheduled material events or corporate event8-KCurrent Reports
May 05 2021Statement of changes in beneficial ownership of securities43,4,5
May 05 2021Statement of changes in beneficial ownership of securities43,4,5
May 05 2021Statement of changes in beneficial ownership of securities43,4,5
May 05 2021Statement of changes in beneficial ownership of securities43,4,5
May 05 2021Statement of changes in beneficial ownership of securities43,4,5
May 05 2021Statement of changes in beneficial ownership of securities43,4,5
May 05 2021Statement of changes in beneficial ownership of securities43,4,5
May 03 2021Report of unscheduled material events or corporate event8-KCurrent Reports
Apr 29 2021Report of unscheduled material events or corporate event8-KCurrent Reports
Apr 29 2021Quarterly report which provides a continuing view of a company's financial position10-QQuarterly Filings
Mar 29 2021EFFECTEFFECTOther
Mar 25 2021EFFECTEFFECTOther
Mar 19 2021Official notification to shareholders of matters to be brought to a vote ("Proxy")DEF 14AProxy Filings
Mar 19 2021Post-effective amendment to an S-Type filingPOS AMRegistration Statements
Mar 19 2021Simplified registration formS-3Registration Statements
Mar 03 2021Statement of changes in beneficial ownership of securities43,4,5
Mar 03 2021Initial filing by director officer or owner of more than ten percent.33,4,5
Mar 03 2021Statement of changes in beneficial ownership of securities43,4,5
Mar 03 2021Statement of changes in beneficial ownership of securities43,4,5
Mar 02 2021Report of unscheduled material events or corporate event8-KCurrent Reports
Feb 25 2021Annual report which provides a comprehensive overview of the company for the past year10-KAnnual Filings
Feb 25 2021Report of unscheduled material events or corporate event8-KCurrent Reports
Feb 16 2021A statement of beneficial ownership of common stock by certain personsSC 13GOther
Feb 05 2021An amendment to the SC 13G filingSC 13G/AOther
Feb 03 2021Statement of changes in beneficial ownership of securities43,4,5
Feb 03 2021Statement of changes in beneficial ownership of securities43,4,5
Feb 03 2021Statement of changes in beneficial ownership of securities43,4,5
Feb 03 2021Statement of changes in beneficial ownership of securities43,4,5
Feb 03 2021Statement of changes in beneficial ownership of securities43,4,5
Feb 01 2021Statement of changes in beneficial ownership of securities43,4,5
Feb 01 2021Statement of changes in beneficial ownership of securities43,4,5
Jan 25 2021Report of unscheduled material events or corporate event8-KCurrent Reports
Jan 05 2021Initial filing by director officer or owner of more than ten percent.33,4,5
Jan 05 2021Initial filing by director officer or owner of more than ten percent.33,4,5
Jan 05 2021An amendment to a 3 filing. Non-EDGAR filing3/A3,4,5
Jan 04 2021Initial filing by director officer or owner of more than ten percent.33,4,5
Jan 04 2021Form of prospectus reflecting facts events constituting substantive change from last form424B3Registration Statements
Jan 04 2021Initial filing by director officer or owner of more than ten percent.33,4,5
Jan 04 2021Initial filing by director officer or owner of more than ten percent.33,4,5
Jan 04 2021Initial filing by director officer or owner of more than ten percent.33,4,5
Jan 04 2021Initial filing by director officer or owner of more than ten percent.33,4,5
Dec 30 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Nov 24 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Nov 12 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Oct 29 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Oct 05 2020An amendment to a SC 13D filingSC 13D/AOther
Sep 25 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Sep 22 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Sep 14 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 27 2020EFFECTEFFECTOther
Aug 27 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 25 2020This filing is a pre-effective amendment to an F-1 filingF-1/ARegistration Statements
Aug 25 2020Amendment to a previously filed 6-K6-K/ACurrent Reports
Aug 20 2020Securities offered to employees pursuant to employee benefit plansS-8Registration Statements
Aug 19 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 17 2020Registration statement for certain foreign private issuersF-1Registration Statements
Aug 14 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 10 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 03 2020An amendment to a SC 13D filingSC 13D/AOther
Jul 31 2020An amendment to a SC 13D filingSC 13D/AOther
Jul 24 2020A statement of beneficial ownership of common stock by certain personsSC 13GOther
Jul 24 2020An amendment to the SC 13G filingSC 13G/AOther
Jul 22 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Jul 20 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Jul 16 2020Amendment to a previously filed 20-F20-F/AAnnual Filings
May 14 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Apr 30 2020Securities offered to employees pursuant to employee benefit plansS-8Registration Statements
Apr 30 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Apr 16 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Apr 14 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Apr 06 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Mar 30 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Mar 10 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Feb 27 2020Registration of securities of foreign private issuers pursuant to section 12(b) or (g)20-FAnnual Filings
Feb 05 2020An amendment to the SC 13G filingSC 13G/AOther
Feb 04 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Jan 17 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Nov 29 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Nov 22 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Nov 22 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Nov 05 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Sep 19 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 14 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 08 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 07 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Jun 05 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 14 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 07 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 03 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Apr 12 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Apr 02 2019Filing by person(s) reporting owned shares of common stock in a public company >5%SC 13DOther
Mar 26 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Mar 26 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Mar 19 2019Registration of securities of foreign private issuers pursuant to section 12(b) or (g)20-FAnnual Filings
Mar 12 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Feb 28 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Feb 12 2019An amendment to the SC 13G filingSC 13G/AOther
Feb 11 2019An amendment to the SC 13G filingSC 13G/AOther
Jan 04 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Nov 06 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Sep 25 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 14 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 07 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Jun 28 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Jun 04 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Jun 01 2018EFFECTEFFECTOther
May 22 2018Registration statement for certain foreign private issuers offered for certain transactionsF-3Registration Statements
May 08 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 04 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 04 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Apr 18 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Mar 29 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Mar 22 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Feb 27 2018Annual Report of foreign issuer rules 13 and 15(d) of the Securities Exchange Act20-FAnnual Filings
Feb 13 2018An amendment to the SC 13G filingSC 13G/AOther
Feb 06 2018An amendment to the SC 13G filingSC 13G/AOther
Jan 26 2018An amendment to a SC 13D filingSC 13D/AOther
Nov 09 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Sep 21 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Sep 12 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 24 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
Aug 08 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 26 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 18 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 12 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
May 09 2017Filing by person(s) reporting owned shares of common stock in a public company >5%SC 13DOther
May 09 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
May 08 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
May 08 2017Filing by person(s) reporting owned shares of common stock in a public company >5%SC 13DOther
May 08 2017Filing by person(s) reporting owned shares of common stock in a public company >5%SC 13DOther
May 05 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
May 05 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
May 03 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
May 01 2017CT ORDERCT ORDEROther
Apr 28 2017Securities offered to employees pursuant to employee benefit plansS-8Registration Statements
Apr 28 2017Form of prospectus disclosing information facts events covered in both forms 424B1 424B3424B4Registration Statements
Apr 26 2017This filing is a pre-effective amendment to an F-1 filingF-1/ARegistration Statements
Apr 26 2017EFFECTEFFECTOther
Apr 26 2017EFFECTEFFECTOther
Apr 26 2017Registration of up to an additional 20% of securities for an offering filed on an F-1F-1MEFRegistration Statements
Apr 21 2017CERTNASCERTNASOther
Apr 19 2017CERTNASCERTNASOther
Apr 19 2017Registration of certain classes of securities 12(b) of the Securities Exchange Act8-A12BRegistration Statements
Apr 18 2017This filing is a pre-effective amendment to an F-1 filingF-1/ARegistration Statements
Apr 18 2017Registration of depository shares evidenced by American Depository ReceiptsF-6Registration Statements
Apr 03 2017Registration statement for certain foreign private issuersF-1Registration Statements
Feb 13 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
Splash

© Verona Pharma plc 2021. All rights reserved